Dr. Langer on Cost Analysis in the Treatment Decision

Corey J. Langer, MD, Professor of Medicine, Director, Thoracic Oncology, Abramson Cancer Center, University of Pennsylvania, explains that as a clinician he does not use cost as a decision factor. The care of the patient and their quality-of-life takes priority over the cost efficacy of a drug. The cost analysis should not be a determining factor for which therapeutic agent to give.